Endometrial cancer stage I

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Universitair Medisch Centrum Utrecht Academic
    IMP not specified
    2024-516708-40-00 1 country 2024 n=10
    Ended

Phase II

1 trial
  • F. Hoffmann-La Roche AG Commercial
    GIREDESTRANT
    2023-504091-23-00 2 countries 2023 n=9
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
F. Hoffmann-La Roche AG Commercial 1 Phase II 0
Universitair Medisch Centrum Utrecht Academic 1 Phase III 0
New trials by year
2023
1
2024
1
← All indication landscapes